Cargando…

SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia

SIRT2 is a member of the NAD+ dependent deacetylases. In this study, the associations between SIRT2 expression and molecular and clinical characteristics of patients with acute myeloid leukemia (AML) were evaluated by data from The Cancer Genome Atlas. SIRT2 was overexpressed in the intermediate- an...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Ailing, Ning, Qiaoyang, Zhou, Lei, Liang, Yaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904374/
https://www.ncbi.nlm.nih.gov/pubmed/27291931
http://dx.doi.org/10.1038/srep27694

Ejemplares similares